Stay updated on Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added. The funding-lapse notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T01:52:52.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding lapse and updated page to Revision: v3.4.1, replacing v3.4.0; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:24:13.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page introduces a glossary toggle and adjusts metadata labels (adding 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0') while removing the prior label 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:15:55.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4; no changes to study content, eligibility, or results are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:18:05.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' in the results status area, and the previous 'No Results Posted' message has been removed.
    Difference
    0.1%
    Check dated 2026-01-06T17:00:46.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The Study Details page updated the Locations section, with state locations added and removed, and the page revision updated to v3.3.3.
    Difference
    0.7%
    Check dated 2025-12-23T09:14:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Triple Negative Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Triple Negative Breast Cancer Clinical Trial page.